Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · IEX Real-Time Price · USD
14.71
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
15.10
+0.39 (2.65%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $377.26 million as of July 22, 2024. Its market cap has increased by 195.20% in one year.
Market Cap
377.26M
Enterprise Value
84.35M
1-Year Change
195.20%
Ranking
Category
Stock Price
$14.71
Market Cap Chart
Since May 7, 2021, Tourmaline Bio's market cap has decreased from $670.10M to $377.26M, a decrease of -43.70%. That is a compound annual growth rate of -16.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 377.30M | -29.13% |
| Dec 29, 2023 | 532.40M | 1,149.77% |
| Dec 30, 2022 | 42.60M | -93.26% |
| Dec 31, 2021 | 632.30M | -5.64% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 397.70M |
| enGene Holdings | 397.05M |
| Organogenesis Holdings | 384.46M |
| Revance Therapeutics | 379.67M |
| Sight Sciences | 378.65M |
| uniQure | 375.77M |
| Lexeo Therapeutics | 368.66M |
| TScan Therapeutics | 365.81M |